Vol:26 | No:03 - DiabetesontheNet

This site is intended for healthcare professionals only

Diabetes &
Primary Care

Vol:26 | No:03
Dec 2024

Filter:

Editorial: A tribute to Dr Michael Mosley

A tribute to the late Michael Mosley and his work as a communicator of the science of lifestyle medicine.

Page: 69

PCDS news: Obesity survey results

Key insights from the PCDS survey on obesity management, conducted in April 2024.

Page: 73

PCDS National Conference 2024: Request for poster abstracts

Poster abstract submissions are invited for the 20th National Conference of the PCDS, which will be held on 6 and 7 November.

Page: 75

Conference over coffee: Physical activity, insulin, CGM, EOT2D and the Alphabet strategy

Key messages to take back to our practice from the 2024 Welsh Conference of the PCDS.

Page: 77

Need to know: Making sense of blood pressure readings in people with diabetes

A printable guide to blood pressure classification and targets in diabetes.

Page: 79

At a glance factsheet: Intermittent fasting for the management of weight and diabetes

The definitions, benefits and risks of intermittent fasting, plus tips for supporting people who wish to adopt these methods.

Page: 81

Q&A: Lipid management – Part 1: Measuring lipids and lipid targets

Claire Davies and Patrick Wainwright answer questions on lipid monitoring, triglycerides, familial hypercholesterolaemia and more.

Page: 85

Q&A: Lipid management – Part 2: Use of statins

Claire Davies answers questions on statin prescribing and monitoring.

Page: 91

Interactive case study: Cardiovascular disease and type 2 diabetes

Primary and secondary prevention of cardiovascular disease, along with glycaemic management, in people with type 2 diabetes.

Page: 97

Diabetes Distilled: Optimising sleep – simple questions and goals

The importance of sleep in type 2 diabetes management.

Page: 99

Diabetes Distilled: UKPDS at 44 years

Persistent benefits reinforce the need to aim for tight glycaemic control as early as possible after type 2 diabetes diagnosis.

Page: 103

Diabetes Distilled: Deep dive into diabetes and infection

The increased risk of, and impaired response to, infection in people with diabetes, and how we can help in primary care.

Page: 105

Diabetes Distilled: Keeping kidneys FLOWing – semaglutide improves renal outcomes

First dedicated randomised controlled trial of kidney outcomes with a GLP-1 receptor agonist shows significant renal and cardiovascular benefits.

Page: 109

Benefits of tirzepatide in obstructive sleep apnoea

ADA 2024: Tirzepatide improves sleep apnoea episodes, both alone and in conjunction with CPAP, in people with OSA and obesity.

Semaglutide effective treatment for HFpEF in people with type 2 diabetes

ADA 2024: Semaglutide improves HFpEF-related symptoms and physical function in people with type 2 diabetes.

SELECT trial: Further analysis shows preventative effects of semaglutide on type 2 diabetes development

ADA 2024: Semaglutide reduces risk of developing type 2 diabetes and increases likelihood of reverting to normoglycaemia in those with prediabetes.

LATEST ARTICLES

Interactive case study: Managing acute illness in type 2 diabetes

Diabetes Distilled: ABCD–UKKA concise recommendations for management of CKD in type 2 diabetes

Welcome to the new PCDS Chair and Secretary

Conference over coffee: Diabetes and obesity initiatives, multiple long-term condition management and the bookends of pregnancy

Scottish Government and NHS Scotland consensus statement on GLP-1-based therapies for obesity

Editorial: Type 2 diabetes, CVD, CKD, dementia and health inequality: Adopting a preventative approach

The dialysis timebomb: Why preventing kidney disease is everyone’s responsibility

For the latest news and articles

Sign up to all DiabetesontheNet journals

Follow us for all the latest news and updates in diabetes.

Resources

Journals

Useful information

© Copyright Omniamed Communications. All Rights Reserved
108 Cannon Street, London, EC4N 6EU. Registered in the United Kingdom

;